{"id":101432,"date":"2020-01-27T06:03:48","date_gmt":"2020-01-27T14:03:48","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/01\/inovios-stock-soars-after-receiving-grant-to-develop-coronavirus-vaccine"},"modified":"2020-01-27T06:03:48","modified_gmt":"2020-01-27T14:03:48","slug":"inovios-stock-soars-after-receiving-grant-to-develop-coronavirus-vaccine","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/01\/inovios-stock-soars-after-receiving-grant-to-develop-coronavirus-vaccine","title":{"rendered":"Inovio\u2019s stock soars after receiving grant to develop coronavirus vaccine"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/inovios-stock-soars-after-receiving-grant-to-develop-coronavirus-vaccine.jpg\"><\/a><\/p>\n<p>The Pennsylvania-based biotechnology company said early Thursday that it was awarded a grant of up to $9 million by the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine for the new strain of coronavirus, 2019-nCoV, which originated in Wuhan, China, and has killed no less than 17 people.<\/p>\n<p>Kim said after the DNA sequence of the new coronavirus strain was made publicly available on Jan. 11, Inovio was able to design and construct a potential vaccine in \u201ca matter of hours,\u201d and the animal-testing process has already begun.<\/p>\n<hr>\n<p>As the coronavirus out of China spreads and gets deadlierof health care companies that announce plans to take part in finding a vaccine, or identifying patients with the new strain, have rallied sharply in very active trading.<\/p>\n<p>On Thursday, among the bigger coronavirus gainers was Inovio Pharmaceuticals Inc.\u2019s stock <a href=\"https:\/\/www.marketwatch.com\/investing\/stock\/ino\">INO +10.42%<\/a>, which ran up 12% to the highest close since May 9. Trading volume swelled to 12.3 million shares, compared with the full-day average over the past 30 days of about 1.4 million shares, according to FactSet.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Pennsylvania-based biotechnology company said early Thursday that it was awarded a grant of up to $9 million by the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine for the new strain of coronavirus, 2019-nCoV, which originated in Wuhan, China, and has killed no less than 17 people. Kim said after the DNA [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495],"tags":[],"class_list":["post-101432","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/101432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=101432"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/101432\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=101432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=101432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=101432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}